Clinical Trial Update: Positioning of Esketamine Treatment in the Real-world Management of Depression [Phase 4]

View source ↗

Summary

Phase 4 study exploring how esketamine is positioned in real-world management of Major Depressive Disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Royal North Shore Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING